World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
23784
World Ranking
2181
National Ranking
85

Tomohiro Morio publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tomohiro Morio sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 483 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tomohiro Morio D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tomohiro Morio sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Tomohiro Morio is affiliated with Tokyo Medical and Dental University in Japan. Their research output spans several key areas in medicine, focusing primarily on immunology, molecular biology, genetics, hematology, and epidemiology.

Their main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology
  • Immunology and Microbiology

Within these broader fields, Morio's subfields of study address specific scientific topics such as:

  • Immunology
  • Genetics
  • Molecular Biology
  • Hematology
  • Epidemiology

Their research primarily covers topics related to immunodeficiency and autoimmune disorders, blood disorders and treatments, and immune cell function and interaction. Additional areas of focus include hematopoietic stem cell transplantation, parvovirus B19 infection studies, autoimmune and inflammatory disorders research, and SARS-CoV-2 and COVID-19 research.

Recent publications highlight their involvement in key updates and classifications within immunology. Notable papers include:

  • Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee (2020, Journal of Clinical Immunology)
  • Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee (2022, Journal of Clinical Immunology)
  • Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification (2020, Journal of Clinical Immunology)
  • Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021, Science Immunology)
  • The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity (2022, Journal of Clinical Immunology)

Morio frequently publishes in several specialized scientific journals. Prominent publication venues include:

  • Journal of Clinical Immunology
  • Pediatrics International
  • International Journal of Hematology
  • Frontiers in Immunology
  • Clinical Immunology

Collaboration is a significant aspect of Morio's work. Frequent co-authors include:

  • Hirokazu Kanegane
  • Kohsuke Imai
  • Masatoshi Takagi
  • Kenichi Kashimada
  • Satoshi Okada

Best Publications

  • Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee

    Stuart G. Tangye;Waleed Al-Herz;Aziz Bousfiha;Talal Chatila

  • International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

    Capucine Picard;H. Bobby Gaspar;Waleed Al-Herz;Aziz Bousfiha

  • Human Tyrosine Kinase 2 Deficiency Reveals Its Requisite Roles in Multiple Cytokine Signals Involved in Innate and Acquired Immunity

    Yoshiyuki Minegishi;Masako Saito;Tomohiro Morio;Ken Watanabe

  • Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.

    Aziz Bousfiha;Leila Jeddane;Capucine Picard;Waleed Al-Herz

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies.

    Aziz Bousfiha;Leïla Jeddane;Capucine Picard;Fatima Ailal

  • Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype.

    Julie Toubiana;Satoshi Okada;Satoshi Okada;Julia Hiller;Matias Oleastro

  • Clinical course of patients with WASP gene mutations

    Kohsuke Imai;Tomohiro Morio;Yi Zhu;Yinzhu Jin

  • Proposed guidelines for diagnosing chronic active epstein-barr virus infection

    Motohiko Okano;Keisei Kawa;Hiroshi Kimura;Akihiro Yachie

  • I[kgr]B[zgr] regulates TH17 development by cooperating with ROR nuclear receptors

    Kazuo Okamoto;Yoshiko Iwai;Masatsugu Oh-hora;Masahiro Yamamoto

  • Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals.

    Masahiro Shinohara;Takako Koga;Kazuo Okamoto;Shinya Sakaguchi

  • Prognostic Factors for Chronic Active Epstein-Barr Virus Infection

    Hiroshi Kimura;Tsuneo Morishima;Hirokazu Kanegane;Shouichi Ohga

  • The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency

    Laura Gámez-Díaz;Dietrich August;Polina Stepensky;Shoshana Revel-Vilk

  • Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2.

    C. L. Ren;T. Morio;Shu Man Fu;R. S. Geha

  • Hematopoietic stem cell–engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses

    Satoru Watanabe;Kazuo Terashima;Shinrai Ohta;Shigeo Horibata

  • BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies

    Beatriz E. Marciano;Chiung Yu Huang;Gyan Joshi;Nima Rezaei

  • Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis

    Sunao Sugita;Norio Shimizu;Ken Watanabe;Miki Mizukami

  • The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

    Unknown

  • X-linked thrombocytopenia (XLT) due to WAS mutations: Clinical characteristics, long-term outcome, and treatment options

    Michael H. Albert;Tanja C. Bittner;Shigeaki Nonoyama;Lucia Dora Notarangelo

  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.

    Jean-Laurent Casanova;Helen C. Su;Covid Human Genetic Effort

  • The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee.

    Stuart G Tangye;Stuart G Tangye;Waleed Al-Herz;Aziz Bousfiha;Charlotte Cunningham-Rundles

Frequent Co-Authors

Kohsuke Imai
Kohsuke Imai Tokyo Medical and Dental University
Hirokazu Kanegane
Hirokazu Kanegane Tokyo Medical and Dental University
Shuki Mizutani
Shuki Mizutani Tokyo Medical and Dental University
Shigeaki Nonoyama
Shigeaki Nonoyama National Defense Medical College
Osamu Ohara
Osamu Ohara Chiba University
Seishi Ogawa
Seishi Ogawa Kyoto University
Seiji Kojima
Seiji Kojima Nagoya University
Hans D. Ochs
Hans D. Ochs University of Washington
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Satoru Miyano
Satoru Miyano Tokyo Medical and Dental University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Immunology in the USA, exploring related healthcare degrees can open diverse career opportunities. Many students pursue advanced nursing programs to complement their immunology background. For instance, the cheapest psychiatric nurse practitioner programs offer affordable routes into specialized mental health care, integrating immunological insights into patient treatment.

Nurses seeking to advance their credentials might consider salary trends by specialty, which vary widely. Understanding the dnp salary by specialty can help in making informed decisions about which field to specialize in, balancing passion with financial goals.

Specialized training is also available for those aiming to shift toward critical care roles. Programs such as acnp programs support family nurse practitioners transitioning to acute care nurse practitioners, broadening clinical expertise in high-stakes environments where immunology plays a vital role.

For accelerated career advancement, online options like the accelerated fnp program enable prospective nurses to fast-track their education and enter the workforce sooner, benefiting from flexible schedules and focused curriculums tailored for rapid skill development.

Best Scientists Citing Tomohiro Morio

Trending Scientists

Recently Published Articles